2012Medical Journal of Chinese People's HealthRequires access

A control study on Citalopram and Buspirone in the treatment of elderly depression

Pei Jing-yun

Open publisher page 0 citations

Abstract

Objective:To study the efficacy and safety of Citalopram combined with Buspirone in the treatment of elderly depression.Methods:90 patients were randomly assigned to two groups: Research group,Citalopram combined with Buspirone;Cotrol grounp,Citalopram only.For 8 weeks,Hamittion depression Sales(HAMD)、 Hamittion Anxiety Sales(HAMA) and treatment emergent Symptams Scale(TESS)were evaluate the clinical efficacy and safely.Results: The Score of HAMD and HAMA reduced significantly in the research group in the2nd week end.(P0.01),in 4、6、8week the two groups were significant difference(P0.01)..Side effects of the research group were less than the control group,between the two groups was statistically significant(P0.01).Conclusions: Citalopram combined with Buspirone in the treatment of elderly depression is effect and safe.Side effects were less.Buspiron may augment the treatment effect of depression with anxiety.

About this research paper

What this paper is about

Objective:To study the efficacy and safety of Citalopram combined with Buspirone in the treatment of elderly depression.Methods:90 patients were randomly assigned to two groups: Research group,Citalopram combined with Buspirone;Cotrol grounp,Citalopram only.For 8 weeks,Hamittion depression Sales(HAMD)、 Hamittion Anxiety Sales(HAMA) and treatment emergent Symptams Scale(TESS)were evaluate the clinical efficacy and safely.Results: The Score of HAMD and HAMA reduced significantly in the research group in the2nd week end.(P0.01),in 4、6、8week the two groups were significant difference(P0.01)..Side effects of the research group were less than the control group,between the two groups was statistically significant(P0.01).Conclusions: Citalopram combined with Buspirone in the treatment of elderly depression is effect and safe.Side effects were less.Buspiron may augment the treatment effect of depression with anxiety.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the efficacy and safety of Citalopram combined with Buspirone in the treatment of elderly depression.Methods:90 patients were randomly assigned to two groups: Research group,Citalopram combined with Buspirone;Cotrol grounp,Citalopram only.For 8 weeks,Hamittion depression Sales(HAMD)、 Hamittion Anxiety Sales(HAMA) and treatment emergent Symptams Scale(TESS)were evaluate the clinical efficacy and safely.Results: The Score of HAMD and HAMA reduced significantly in the research group in the2nd week end.(P0.01),in 4、6、8week the two groups were significant difference(P0.01)..Side effects of the research group were less than the control group,between the two groups was statistically significant(P0.01).Conclusions: Citalopram combined with Buspirone in the treatment of elderly depression is effect and safe.Side effects were less.Buspiron may augment the treatment effect of depression with anxiety.

Key concepts: Buspirone, Hamd, Citalopram, Depression (economics), Anxiety, Psychology, Medicine, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
A control study on Citalopram and Buspirone in the treatment of elderly depression — Research Paper | ScholarLens